Blue Owl Capital Holdings’s Cullinan Oncology CGEM Stock Holding History

Blue Owl Capital Holdings’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.1M	Sell	1,909,764 -441,208	-19%	-$5.67M	7.36%	5
2025 Q4	$24.3M	Sell	2,350,972 -160,000	-6%	-$1.44M	7.51%	5
2025 Q3	$14.9M	Buy	2,510,972 +125,000	+5%	+$915K	4.62%	8
2025 Q2	$18M	Sell	2,385,972 -50,000	-2%	-$402K	5.8%	3
2025 Q1	$18.4M	Buy	2,435,972 +65,000	+3%	+$624K	5.95%	3
2024 Q4	$28.9M	Buy	2,370,972 +360,000	+18%	+$5.17M	6.65%	5
2024 Q3	$33.7M	Sell	2,010,972 -38,200	-2%	-$678K	6.53%	5
2024 Q2	$35.7M	Sell	2,049,172 -875,670	-30%	-$18.6M	9.94%	1
2024 Q1	$49.8M	Sell	2,924,842 -495,000	-14%	-$7.65M	9.96%	2
2023 Q4	$34.8M	Buy	+3,419,842	New	+$30.3M	8.33%	3

Other funds holding CGEM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return